Example: Heart Attack

Clinical Trials on Central Nervous System Neoplasms

Total 1964 results

NCT01941758

Completed

High-Dose Trivalent Influenza Vaccine in Inducing Immune Response Patients With Central Nervous System Tumors

Conditions: Central Nervous System Neoplasm
NCT01474174

Completed

Trivalent Influenza Vaccine in Preventing Flu in Patients With Central Nervous System Tumors

Conditions: Central Nervous System Neoplasm
NCT04096716

Recruiting

Mapping Draining Lymph Nodes in CNS Malignancies

Conditions: Central Nervous System Neoplasms; Central Nervous System Tumor
NCT04217694

Recruiting

Memantine for the Reduction of Cognitive Impairment After Radiation Therapy in Pediatric Patients With Central Nervous System Tumors

Conditions: Malignant Central Nervous System Neoplasm; Primary Central Nervous System Neoplasm
NCT04276194

Recruiting

Vertebral Body Sparing Craniospinal Irradiation for Pediatric Patients With Cancer of the Central Nervous System

Conditions: Malignant Central Nervous System Neoplasm
NCT02462629

Completed

Study of BLZ-100 in Pediatric Subjects With CNS Tumors

Conditions: Central Nervous System Tumors
NCT03579602

Recruiting

Study of Tozuleristide and the Canvas Imaging System in Pediatric Subjects With CNS Tumors Undergoing Surgery

Conditions: Pediatric Central Nervous System Tumor
NCT03050450

Suspended

Study of Lenalidomide With Vorinostat in Pediatric Patients With High Grade or Progressive CNS Tumors

Conditions: Central Nervous System Tumors
NCT02710240

Active, not recruiting

Indocyanine Green for Central Nervous System Tumors

Conditions: Suspected Central Nervous System Tumors
NCT01538095

Completed

Trebananib in Treating Younger Patients With Relapsed or Refractory Solid Tumors, Including Central Nervous System Tumors

Conditions: Central Nervous System Neoplasm; Solid Neoplasm
NCT00897858

Withdrawn

Studying Cerebrospinal Fluid Proteins and Angiogenesis Proteins in Young Patients With Newly Diagnosed Central Nervous System Tumors

Conditions: Brain and Central Nervous System Tumors
NCT01158300

Completed

PTC299 in Treating Young Patients With Refractory or Recurrent Primary Central Nervous System Tumors

Conditions: Brain and Central Nervous System Tumors
NCT04671368

Not yet recruiting

Diagnostic Efficiency of Artificial Intelligence for Surgical Neuropathology

Conditions: Central Nervous System Neoplasms
NCT03554707

Not yet recruiting

SGT-53 in Children With Recurrent or Progressive CNS Malignancies

Conditions: Childhood CNS Tumor
NCT00572182

Terminated

MK0752 in Treating Young Patients With Recurrent or Refractory CNS Cancer

Conditions: Brain and Central Nervous System Tumors
NCT02797366

Recruiting

Proton Radiotherapy for Primary Central Nervous System Tumours in Adults

Conditions: Central Nervous System Tumour; Arteriovenous Malformation
NCT00003765

Completed

O6-benzylguanine and Carmustine in Treating Children With Refractory CNS Tumors

Conditions: Brain and Central Nervous System Tumors
NCT03565367

Suspended

Hyperpolarized Carbon C 13 Pyruvate Magnetic Resonance Spectroscopic Imaging in Detecting Lactate and Bicarbonate in Participants With Central Nervous System Tumors

Conditions: Malignant Central Nervous System Neoplasm; Metastatic Malignant Neoplasm in the Central Nervous System
NCT03055364

Recruiting

Cognitive Function After Treatment of Primary CNS Malignancy

Conditions: CNS Malignancy
NCT00876993

Completed

Study of Irinotecan and Bevacizumab With Temozolomide in Refractory/Relapsed Central Nervous System (CNS) Tumors

Conditions: Central Nervous System Tumors
NCT03052738

Recruiting

Medical Marijuana in the Pediatric Central Nervous System Tumor Population

Conditions: Central Nervous System Tumor; Brain Tumor; Spinal Tumor
NCT02095353

Terminated

Comparison of Contrast Agents for MRI Perfusion Analysis in Brain Tumor Patients

Conditions: Central Nervous System Neoplasms
NCT01595126

Unknown status

Longitudinal Study of Biomarkers

Conditions: Central Nervous System Tumor
NCT02050243

Unknown status

The Use of 5-aminolevulinic Acid (ALA) as an Intraoperative Tumor Marker for Resection of Pediatric Central Nervous System (CNS) Tumors

Conditions: Central Nervous System Tumor, Pediatric
NCT01180881

Active, not recruiting

Neurobehavioral Functioning in Pediatric Brain Tumor Patients After Proton Beam Radiation Treatment

Conditions: Brain Tumor; Central Nervous System Neoplasms